Employee stories Lina Digital Project Manager Read story here Bobby Associate Medical Writer Read story here Sarah Senior Medical Writer Read story here Amina Account Executive Read story here Claire Senior Editor Read story here Paul Group Communications Director Read story here Load more employee stories Follow us on Twitter POSTED ON 23 NOV 2021 Will your cross-functional planning suffer because nobody brought the salad? For agencies supporting #Pharma companies, it's essential to bring expertise from across functions and to help clients to de-silo. This article by @Richard_PharmaG explains why:https://t.co/yFrUUyEvNp https://t.co/AH8giBViL6 Get in touch © 2021 Oxford PharmaGenesis Terms Privacy and Security COVID-19 Statement GPG report We'll assume you're ok with this, but you can opt-out if you wish.

Rare Diseases Share this page We care passionately about rare diseases and orphan drugs, which pose unique challenges for patient management, drug development and market access. With our unrivalled heritage and extensive networks of stakeholders across multiple therapy areas, we succeed in this distinctive area of medicine by collaborating with and building trust among all involved. By focusing on the disease and the disease community, we ensure that every activity ultimately serves the patient community. Our key service offerings include: strategic disease area landscape analysis patient engagement and advocacy targeted medical education programmes stakeholder events, including advisory boards and symposia strategic publications planning and delivery disease area registries value proposition development Enquiries Get in touch © 2021 Oxford PharmaGenesis Terms Privacy and Security COVID-19 Statement GPG report

Policy Share this page Bringing new medicines to the world in areas of unmet medical need requires coordination of political, scientific, regulatory and economic dimensions. As a result, existing systems and support structures may need radical transformation in order to provide an appropriate environment for the introduction of new, evidence-based therapies. Our dedicated health policy team is committed to delivering evidence-based policy initiatives to improve global public health. Our key service offerings include: policy landscape analysis robust, evidence-based policy reports developed with renowned experts dissemination plans for policy recommendations through networks, congresses and journals stakeholder engagement tools to drive policy change awareness-raising activities involving policy makers, advocates and influential groups Enquiries Get in touch © 2021 Oxford PharmaGenesis Terms Privacy and Security COVID-19 Statement GPG report